Insulin Potentiated Therapy (IPT) is an integrative oncology approach in which a small, carefully controlled dose of insulin is administered before low-dose chemotherapy. The idea behind IPT cancer treatment is to harness insulin's biological effects on cellular metabolism to enable chemotherapy drugs to be delivered at significantly reduced doses.
IPT is offered at certain specialist clinics in Germany as part of a personalised, multidisciplinary treatment plan, not as a stand-alone cure. It is typically considered alongside, or in support of, conventional oncology care.
Key points about insulin potentiation therapy:
- It uses low-dose chemotherapy combined with insulin
- It is delivered under continuous medical supervision
- It forms part of a wider integrative treatment plan
- Suitability is decided on a case-by-case basis after a full oncology evaluation
How Does IPT Therapy Work?
While protocols vary between clinics, IPT therapy generally follows this sequence under hospital conditions:
- Patient assessment - Blood work, imaging review, and oncology consultation.
- Insulin administration - A measured dose of insulin is given intravenously.
- Controlled metabolic window - Blood sugar is closely monitored as it lowers temporarily.
- Low-dose chemotherapy delivery - A reduced dose of chemotherapy is administered during this window.
- Glucose restoration and monitoring - Blood sugar is normalised, and the patient is observed throughout recovery.
- Supportive integrative care - Nutritional, immune, and wellness support follows each session.
This metabolic cancer therapy approach aims to deliver chemotherapy at lower doses than conventional protocols, which some patients and clinicians believe may help reduce side-effect burden. Clinical evidence remains limited, and IPT is not currently classified as standard-of-care oncology treatment.
